Latest News & Research

Smoking cessation in chronic kidney disease

The RACP internal medicine journal has just released 'Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach'. 

Chronic kidney disease (CKD) is a significant public health challenge in Australia and affects about 10% of the population, with substantial morbidity and mortality. 

Training clinicians in smoking cessation interventions

Research shows that training clinicians in smoking cessation methods may increase patients' cessation rates.

Updated PSA guidelines

The Pharmaceutical Society of Australia has recently updated its guidelines (December 2025) for pharmacists providing smoking and vaping cessation support in response to the regulatory changes in 2024 and 2025.

New CPD activities for GPs

Thanks to your insightful feedback, we have enhanced our three GP online training modules, providing opportunities for reflection, consolidating your learning and using the information in your practice.

Supporting young patients to quit

The latest National Child Health Poll from The Royal Children’s Hospital asked Australian parents and children aged between 12 and 17 years about their knowledge, attitudes, and behaviours related to nicotine products including cigarettes, vapes and oral nicotine pouches. 

New Pharmacist training from PSA

The Pharmaceutical Society of Australia (PSA) has launched a new training module on advancing practice in supply and dispensing of nicotine vaping products.

For patients with COPD who smoke, it's never too late to quit

A recently published comprehensive analysis revealed important benefits of smoking cessation in Chronic Pulmonary Obstructive Disease (COPD). It is never too late to quit, and smoking cessation care is a matter of priority for all patients with COPD who smoke.